Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 60Head and Neck Neoplasms 22Squamous Cell Carcinoma of Head and Neck 21Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Melanoma 17Colonic Neoplasms 16Rectal Neoplasms 15Carcinoma, Renal Cell 13Pancreatic Neoplasms 12Lymphoma 12Prostatic Neoplasms 11Ovarian Neoplasms 11Lymphoma, Follicular 11Carcinoma, Ovarian Epithelial 11Kidney Neoplasms 9Breast Neoplasms, Male 9Salivary Gland Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Central Nervous System Neoplasms 8Sarcoma 7Liver Neoplasms 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Unspecified Adult Solid Tumor, Protocol Specific 6Neuroblastoma 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma, B-Cell, Marginal Zone 6

Interventions

pembrolizumab 14Injections 13Paclitaxel 10Nivolumab 10Docetaxel 9Cisplatin 9Capecitabine 9Bevacizumab 8toripalimab 7senaparib 7Fluorodeoxyglucose F18 7Cyclophosphamide 7tislelizumab 6atezolizumab 6Irinotecan 6Fluorouracil 6Gemcitabine 5fludarabine 4apatinib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4Carboplatin 4spartalizumab 3sintilimab 3pertuzumab 3olaparib 3camrelizumab 3Rifampin 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor × Immunohistochemistry × Clear all
NCT00483457 2012-09-03

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

Vanderbilt-Ingram Cancer Center

Completed
33 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡